Estonia vs Norway: The number of people with susceptibility test result for rifampicin
Estonia
74
in 2021
Norway
69
in 2021
Estonia rank
113th
Norway rank
114th
The number of people with susceptibility test result for rifampicin over time
- Estonia
- Norway
How they compare
Estonia currently reports 74 against 69 in Norway, a difference of 5.
That makes Estonia's figure about 1.1 times Norway's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Norway ahead.
Estonia ranks 113th and Norway ranks 114th of 155 countries.
Estonia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Estonia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 111 | 105.33 | 5.67 | Estonia |
| 2020s | 82.5 | 75 | 7.5 | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Estonia or Norway?
- Estonia, at 74 against 69 in Norway as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Estonia and Norway?
- 5, with Estonia ahead.
- How many years of comparable data are there for Estonia and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Estonia and Norway rank globally for the number of people with susceptibility test result for rifampicin?
- Estonia ranks 113th and Norway ranks 114th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.